Epidemiology and etiology of Alzheimer's disease: from genetic to non-genetic factors.
暂无分享,去创建一个
L. Tan | Yan Tian | T. Jiang | Jin-Tai Yu | Teng Jiang
[1] C. Rowe,et al. Physical activity and amyloid-β plasma and brain levels: results from the Australian Imaging, Biomarkers and Lifestyle Study of Ageing , 2013, Molecular Psychiatry.
[2] L. Calvó-Perxas,et al. Depression subtypes and 5‐year risk of dementia and Alzheimer disease in patients aged 70 years , 2013, International journal of geriatric psychiatry.
[3] W. Thies,et al. 2013 Alzheimer's disease facts and figures , 2013, Alzheimer's & Dementia.
[4] F. Thinnes. Why cancer survivors have a lower risk of Alzheimer disease. , 2012, Molecular genetics and metabolism.
[5] D. Perl,et al. Dementia resulting from traumatic brain injury: what is the pathology? , 2012, Archives of neurology.
[6] J. Schneider,et al. Overview and findings from the religious orders study. , 2012, Current Alzheimer research.
[7] N. Zawia,et al. Applying epigenetics to Alzheimer's disease via the latent early-life associated regulation (LEARn) model. , 2012, Current Alzheimer research.
[8] G. Schellenberg,et al. The genetics and neuropathology of Alzheimer’s disease , 2012, Acta Neuropathologica.
[9] V. Kyriazopoulou,et al. Ghrelin and leptin secretion in patients with moderate Alzheimer’s disease , 2012, The journal of nutrition, health & aging.
[10] E. Marcantonio,et al. Anesthetics isoflurane and desflurane differently affect mitochondrial function, learning, and memory , 2012, Annals of neurology.
[11] K. Yaffe,et al. Midlife vs late-life depressive symptoms and risk of dementia: differential effects for Alzheimer disease and vascular dementia. , 2012, Archives of general psychiatry.
[12] W. Jagust,et al. Association of lifetime cognitive engagement and low β-amyloid deposition. , 2012, Archives of neurology.
[13] D A Bennett,et al. Total daily physical activity and the risk of AD and cognitive decline in older adults , 2012, Neurology.
[14] L. Buée,et al. Tau Phosphorylation and Sevoflurane Anesthesia: An Association to Postoperative Cognitive Impairment , 2012, Anesthesiology.
[15] J. Schröder,et al. Cognitive activity, education and socioeconomic status as preventive factors for mild cognitive impairment and Alzheimer's disease , 2012, Psychiatry Research.
[16] Sudha Seshadri,et al. Inverse association between cancer and Alzheimer’s disease: results from the Framingham Heart Study , 2012, BMJ : British Medical Journal.
[17] C. McCollum,et al. Association of cerebral emboli with accelerated cognitive deterioration in Alzheimer's disease and vascular dementia. , 2012, The American journal of psychiatry.
[18] V. Haroutunian,et al. Hypertension is associated with cognitive decline in elderly people at high risk for dementia. , 2012, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.
[19] Luc Verschaeve,et al. Can cytogenetics explain the possible association between exposure to extreme low‐frequency magnetic fields and Alzheimer's disease? , 2012, Journal of applied toxicology : JAT.
[20] A. Brickman,et al. Memory after silent stroke , 2012, Neurology.
[21] J. Beyene,et al. Exposure to general anesthesia and risk of alzheimer's disease: a systematic review and meta-analysis , 2011, BMC geriatrics.
[22] Zheng-rong Wang,et al. The association of antihypertensive medication use with risk of cognitive decline and dementia: a meta‐analysis of longitudinal studies , 2011, International journal of clinical practice.
[23] R. Honea,et al. Alzheimer disease biomarkers are associated with body mass index , 2011, Neurology.
[24] L. Launer,et al. Microinfarcts, brain atrophy, and cognitive function: The Honolulu Asia Aging Study Autopsy Study , 2011, Annals of neurology.
[25] H. Hanyu,et al. Efficacy of PPAR-γ agonist pioglitazone in mild Alzheimer disease , 2011, Neurobiology of Aging.
[26] M. Sano,et al. A randomized, double-blind, placebo-controlled trial of simvastatin to treat Alzheimer disease , 2011, Neurology.
[27] L. Launer,et al. White Matter Lesions on Brain Magnetic Resonance Imaging Scan and 5‐Year Cognitive Decline: The Honolulu‐Asia Aging Study , 2011, Journal of the American Geriatrics Society.
[28] Huadong Zhou,et al. Cerebral ischemia aggravates cognitive impairment in a rat model of Alzheimer's disease. , 2011, Life sciences.
[29] N. Kandiah,et al. White Matter Disease Independently Predicts Progression from Mild Cognitive Impairment to Alzheimer’s Disease in a Clinic Cohort , 2011, Dementia and Geriatric Cognitive Disorders.
[30] S. Kanba,et al. Midlife and Late-Life Blood Pressure and Dementia in Japanese Elderly: The Hisayama Study , 2011, Hypertension.
[31] H. Arai,et al. Adiponectin in plasma and cerebrospinal fluid in MCI and Alzheimer’s disease , 2011, European journal of neurology.
[32] L. Fratiglioni,et al. Midlife overweight and obesity increase late-life dementia risk , 2011, Neurology.
[33] K. Anstey,et al. Body mass index in midlife and late‐life as a risk factor for dementia: a meta‐analysis of prospective studies , 2011, Obesity reviews : an official journal of the International Association for the Study of Obesity.
[34] Denise C. Park,et al. Toward defining the preclinical stages of Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease , 2011, Alzheimer's & Dementia.
[35] J. Morris,et al. The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease , 2011, Alzheimer's & Dementia.
[36] M. Albert,et al. Introduction to the recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease , 2011, Alzheimer's & Dementia.
[37] A. Brickman,et al. Physical activity and Alzheimer disease course. , 2011, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.
[38] Nick C Fox,et al. Common variants in ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer’s disease , 2011, Nature Genetics.
[39] D. G. Clark,et al. Common variants in MS4A4/MS4A6E, CD2uAP, CD33, and EPHA1 are associated with late-onset Alzheimer’s disease , 2011, Nature Genetics.
[40] H. Urbach,et al. Comment on: Brain Microbleeds and Alzheimer’s Disease: Innocent Observation or Key Player? , 2011, Clinical Neuroradiology.
[41] R. Mayeux,et al. Epidemiology of Alzheimer disease , 2011, Nature Reviews Neurology.
[42] S. Leurgans,et al. Microinfarct Pathology, Dementia, and Cognitive Systems , 2011, Stroke.
[43] Minna Rusanen,et al. Heavy smoking in midlife and long-term risk of Alzheimer disease and vascular dementia. , 2011, Archives of internal medicine.
[44] E. Wijsman,et al. Genome-Wide Association of Familial Late-Onset Alzheimer's Disease Replicates BIN1 and CLU and Nominates CUGBP2 in Interaction with APOE , 2011, PLoS genetics.
[45] N. Pivac,et al. Serum lipid levels in patients with Alzheimer's disease. , 2011, Collegium antropologicum.
[46] J. Geiger,et al. Caffeine protects against oxidative stress and Alzheimer's disease-like pathology in rabbit hippocampus induced by cholesterol-enriched diet. , 2010, Free radical biology & medicine.
[47] D. Bennett,et al. Where Vascular Meets Neurodegenerative Disease , 2010, Stroke.
[48] H. Soininen,et al. Midlife Smoking, Apolipoprotein E and Risk of Dementia and Alzheimer’s Disease: A Population-Based Cardiovascular Risk Factors, Aging and Dementia Study , 2010, Dementia and Geriatric Cognitive Disorders.
[49] J. Gilbert,et al. Dementia Revealed: Novel Chromosome 6 Locus for Late-Onset Alzheimer Disease Provides Genetic Evidence for Folate-Pathway Abnormalities , 2010, PLoS genetics.
[50] S. Kanba,et al. Insulin resistance is associated with the pathology of Alzheimer disease , 2010, Neurology.
[51] Michael W. Weiner,et al. Obesity is linked with lower brain volume in 700 AD and MCI patients , 2010, Neurobiology of Aging.
[52] P. Wolf,et al. Depressive symptoms and risk of dementia , 2010, Neurology.
[53] A. Zonderman,et al. Recurrent depressive symptoms and the incidence of dementia and mild cognitive impairment , 2010, Neurology.
[54] A. Atri,et al. Effects of Simvastatin on Cholesterol Metabolism and Alzheimer Disease Biomarkers , 2010, Alzheimer disease and associated disorders.
[55] A. Işık,et al. The relationship between body mass index and incidental mild cognitive impairment, Alzheimer’s disease, and Vascular Dementia in elderly , 2010, The journal of nutrition, health & aging.
[56] Sudha Seshadri,et al. Genome-wide analysis of genetic loci associated with Alzheimer disease. , 2010, JAMA.
[57] M. H. Walsh,et al. Actions of adiponectin on the excitability of subfornical organ neurons are altered by food deprivation , 2010, Brain Research.
[58] K. Welsh-Bohmer,et al. Occupational exposure to pesticides increases the risk of incident AD , 2010, Neurology.
[59] Douglas H. Smith,et al. Traumatic brain injury and amyloid-β pathology: a link to Alzheimer's disease? , 2010, Nature Reviews Neuroscience.
[60] P. S. St George-Hyslop,et al. The effect of alcohol and tobacco consumption, and apolipoprotein E genotype, on the age of onset in Alzheimer's disease , 2010, International journal of geriatric psychiatry.
[61] N. Lunet,et al. Caffeine intake and dementia: systematic review and meta-analysis. , 2010, Journal of Alzheimer's disease : JAD.
[62] J. Geiger,et al. Caffeine protects against disruptions of the blood-brain barrier in animal models of Alzheimer's and Parkinson's diseases. , 2010, Journal of Alzheimer's disease : JAD.
[63] M. Kivipelto,et al. Caffeine as a protective factor in dementia and Alzheimer's disease. , 2010, Journal of Alzheimer's disease : JAD.
[64] K. Ritchie,et al. Caffeine intake is associated with a lower risk of cognitive decline: a cohort study from Portugal. , 2010, Journal of Alzheimer's disease : JAD.
[65] Bryan Maloney,et al. The “LEARn” (Latent Early-life Associated Regulation) model integrates environmental risk factors and the developmental basis of Alzheimer’s disease, and proposes remedial steps , 2010, Experimental Gerontology.
[66] Z. Zuo,et al. Spine Surgery under General Anesthesia May Not Increase the Risk of Alzheimer’s Disease , 2010, Dementia and Geriatric Cognitive Disorders.
[67] Ana M. García,et al. Isolated and joint effects of tobacco and alcohol consumption on risk of Alzheimer's disease. , 2010, Journal of Alzheimer's disease : JAD.
[68] D. Sparks,et al. Randomized controlled trial of atorvastatin in mild to moderate Alzheimer disease , 2010, Neurology.
[69] Anton P. Porsteinsson,et al. Meta-Analysis of Alzheimer's Disease Risk with Obesity, Diabetes, and Related Disorders , 2010, Biological Psychiatry.
[70] D. Sparks,et al. Cholesterol and Cognitive Performance in Normal Controls and the Influence of Elective Statin Use after Conversion to Mild Cognitive Impairment: Results in a Clinical Trial Cohort , 2010, Neurodegenerative Diseases.
[71] Filippo Caraci,et al. Depression and Alzheimer's disease: neurobiological links and common pharmacological targets. , 2010, European journal of pharmacology.
[72] Sudha Seshadri,et al. Association of plasma leptin levels with incident Alzheimer disease and MRI measures of brain aging. , 2009, JAMA.
[73] Zina Kroner,et al. The relationship between Alzheimer's disease and diabetes: Type 3 diabetes? , 2009, Alternative medicine review : a journal of clinical therapeutic.
[74] M. Barcikowska,et al. PIN1 gene variants in Alzheimer's disease , 2009, BMC Medical Genetics.
[75] M. Taouis,et al. Adiponectin and energy homeostasis: consensus and controversy. , 2009, The Journal of nutritional biochemistry.
[76] N. Zawia,et al. The LEARn model: an epigenetic explanation for idiopathic neurobiological diseases , 2009, Molecular Psychiatry.
[77] J. Dartigues,et al. Leisure activities and the risk of dementia in the elderly , 2009, Neurology.
[78] Nick C Fox,et al. Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease, and shows evidence for additional susceptibility genes , 2009, Nature Genetics.
[79] J. Kaprio,et al. Coffee drinking in middle age is not associated with cognitive performance in old age. , 2009, The American journal of clinical nutrition.
[80] O. Hanon,et al. Effects of antihypertensive therapy on cognitive decline in Alzheimer's disease. , 2009, American journal of hypertension.
[81] Andrew J. Saykin,et al. Hippocampal Atrophy as a Quantitative Trait in a Genome-Wide Association Study Identifying Novel Susceptibility Genes for Alzheimer's Disease , 2009, PloS one.
[82] C. Lendon,et al. A common biological mechanism in cancer and Alzheimer's disease? , 2009, Current Alzheimer research.
[83] E. Larson,et al. Association between late-life body mass index and dementia , 2009, Neurology.
[84] V. Haroutunian,et al. Less Alzheimer disease neuropathology in medicated hypertensive than nonhypertensive persons , 2009, Neurology.
[85] A. Hofman,et al. Duration of antihypertensive drug use and risk of dementia , 2009, Neurology.
[86] R. Kenny,et al. Blood pressure and the risk for dementia—A double edged sword , 2009, Ageing Research Reviews.
[87] B. Winblad,et al. Uncontrolled diabetes increases the risk of Alzheimer’s disease: a population-based cohort study , 2009, Diabetologia.
[88] Lewis H Kuller,et al. Midlife and late-life obesity and the risk of dementia: cardiovascular health study. , 2009, Archives of neurology.
[89] V. Pankratz,et al. Genetic variation in PCDH11X is associated with susceptibility to late-onset Alzheimer's disease , 2009, Nature Genetics.
[90] Eden R Martin,et al. Genome-wide association study implicates a chromosome 12 risk locus for late-onset Alzheimer disease. , 2009, American journal of human genetics.
[91] S E Poduslo,et al. Genome screen of late‐onset Alzheimer's extended pedigrees identifies TRPC4AP by haplotype analysis , 2009, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.
[92] L. Fratiglioni,et al. Mid- and Late-Life Diabetes in Relation to the Risk of Dementia , 2009, Diabetes.
[93] P. Davies,et al. Therapeutic potential of resveratrol in Alzheimer's disease , 2008, BMC Neuroscience.
[94] Christoph Lange,et al. Genome-wide association analysis reveals putative Alzheimer's disease susceptibility loci in addition to APOE. , 2008, American journal of human genetics.
[95] A Hofman,et al. Statins are associated with a reduced risk of Alzheimer disease regardless of lipophilicity. The Rotterdam Study , 2008, Journal of Neurology, Neurosurgery, and Psychiatry.
[96] Sudha Seshadri,et al. Association of alcohol consumption with brain volume in the Framingham study. , 2008, Archives of neurology.
[97] L. Lannfelt,et al. Impaired insulin secretion increases the risk of Alzheimer disease , 2008, Neurology.
[98] J. Feldon,et al. The impact of voluntary exercise on mental health in rodents: A neuroplasticity perspective , 2008, Behavioural Brain Research.
[99] C. Bulpitt,et al. Alcohol, dementia and cognitive decline in the elderly: a systematic review. , 2008, Age and ageing.
[100] V. Pankratz,et al. Association of duration and severity of diabetes mellitus with mild cognitive impairment. , 2008, Archives of neurology.
[101] M. Hamer,et al. Physical activity and risk of neurodegenerative disease: a systematic review of prospective evidence , 2008, Psychological Medicine.
[102] D. Bennett,et al. Change in depressive symptoms during the prodromal phase of Alzheimer disease. , 2008, Archives of general psychiatry.
[103] Ana M. García,et al. Occupational exposure to extremely low frequency electric and magnetic fields and Alzheimer disease: a meta-analysis. , 2008, International journal of epidemiology.
[104] A. Hofman,et al. Prestroke Cognitive Performance, Incident Stroke, and Risk of Dementia: The Rotterdam Study , 2008, Stroke.
[105] D A Bennett,et al. Relation of cognitive activity to risk of developing Alzheimer disease , 2007, Neurology.
[106] Kaarin J Anstey,et al. Smoking as a risk factor for dementia and cognitive decline: a meta-analysis of prospective studies. , 2007, American journal of epidemiology.
[107] Kathryn Ziegler-Graham,et al. Forecasting the global burden of Alzheimer’s disease , 2007, Alzheimer's & Dementia.
[108] C. Tseng,et al. A case-control study of occupational magnetic field exposure and Alzheimer's disease: results from the California Alzheimer's Disease Diagnosis and Treatment Centers , 2007, BMC neurology.
[109] Winnie S. Liang,et al. GAB2 Alleles Modify Alzheimer's Risk in APOE ɛ4 Carriers , 2007, Neuron.
[110] Rebecca F. Halperin,et al. A high-density whole-genome association study reveals that APOE is the major susceptibility gene for sporadic late-onset Alzheimer's disease. , 2007, The Journal of clinical psychiatry.
[111] M. Gill,et al. Evidence for novel susceptibility genes for late-onset Alzheimer's disease from a genome-wide association study of putative functional variants. , 2007, Human molecular genetics.
[112] N. Zawia,et al. How and when environmental agents and dietary factors affect the course of Alzheimer's disease: the "LEARn" model (latent early-life associated regulation) may explain the triggering of AD. , 2007, Current Alzheimer research.
[113] A. Murray,et al. Autonomic dysfunction in dementia , 2006, Journal of Neurology, Neurosurgery & Psychiatry.
[114] Hong Qing,et al. Hypoxia facilitates Alzheimer's disease pathogenesis by up-regulating BACE1 gene expression , 2006, Proceedings of the National Academy of Sciences.
[115] L. Zacharia,et al. Caffeine protects Alzheimer’s mice against cognitive impairment and reduces brain β-amyloid production , 2006, Neuroscience.
[116] J. Langlois,et al. Incidence of Traumatic Brain Injury in the United States, 2003 , 2006, The Journal of head trauma rehabilitation.
[117] A. Seidler,et al. Occupational exposure to low frequency magnetic fields and dementia: a case–control study , 2006, Occupational and Environmental Medicine.
[118] Avshalom Caspi,et al. Gene–environment interactions in psychiatry: joining forces with neuroscience , 2006, Nature Reviews Neuroscience.
[119] David Loewenstein,et al. Depression and risk for Alzheimer disease: systematic review, meta-analysis, and metaregression analysis. , 2006, Archives of general psychiatry.
[120] Lenore J Launer,et al. Reducing the Risk of Dementia: Efficacy of Long-Term Treatment of Hypertension , 2006, Stroke.
[121] L. Fratiglioni,et al. Role of genes and environments for explaining Alzheimer disease. , 2006, Archives of general psychiatry.
[122] Li Wang,et al. Exercise Is Associated with Reduced Risk for Incident Dementia among Persons 65 Years of Age and Older , 2006, Annals of Internal Medicine.
[123] C. Mathers,et al. Global prevalence of dementia: a Delphi consensus study , 2005, The Lancet.
[124] B. Winblad,et al. Leisure-time physical activity at midlife and the risk of dementia and Alzheimer's disease , 2005, The Lancet Neurology.
[125] M. Reger,et al. Preserved Cognition in Patients With Early Alzheimer Disease and Amnestic Mild Cognitive Impairment During Treatment With Rosiglitazone: A Preliminary Study , 2005 .
[126] N. Lautenschlager,et al. Dementia associated with alcohol and other drug use , 2005, International Psychogeriatrics.
[127] B. Winblad,et al. The age-dependent relation of blood pressure to cognitive function and dementia , 2005, The Lancet Neurology.
[128] A. Hofman,et al. Cerebral hypoperfusion and clinical onset of dementia: The Rotterdam study , 2005, Annals of neurology.
[129] M. M. Mielke,et al. High total cholesterol levels in late life associated with a reduced risk of dementia , 2005, Neurology.
[130] Kristine Yaffe,et al. Obesity in middle age and future risk of dementia: a 27 year longitudinal population based study , 2005, BMJ : British Medical Journal.
[131] Bernd W. Brandt,et al. Variation in the human TP53 gene affects old age survival and cancer mortality1 , 2005, Experimental Gerontology.
[132] K Yaffe,et al. Midlife cardiovascular risk factors and risk of dementia in late life , 2005, Neurology.
[133] B. Winblad,et al. Occupational Exposure to Electromagnetic Fields and Risk of Alzheimer's Disease , 2004, Epidemiology.
[134] P. Elias,et al. Blood Pressure-Related Cognitive Decline: Does Age Make a Difference? , 2004, Hypertension.
[135] B. Winblad,et al. Alcohol drinking in middle age and subsequent risk of mild cognitive impairment and dementia in old age: a prospective population based study , 2004, BMJ : British Medical Journal.
[136] Freya Kamel,et al. Association of Pesticide Exposure with Neurologic Dysfunction and Disease , 2004, Environmental health perspectives.
[137] K. Lu. Pinning down cell signaling, cancer and Alzheimer's disease. , 2004, Trends in biochemical sciences.
[138] N. Pedersen,et al. How heritable is Alzheimer's disease late in life? Findings from Swedish twins , 2004, Annals of neurology.
[139] C B Hall,et al. Low blood pressure and the risk of dementia in very old individuals , 2003, Neurology.
[140] R. Mayeux,et al. Stroke and the risk of Alzheimer disease. , 2003, Archives of neurology.
[141] D. Bennett,et al. Alzheimer disease in the US population: prevalence estimates using the 2000 census. , 2003, Archives of neurology.
[142] S Rabe-Hesketh,et al. Head injury as a risk factor for Alzheimer’s disease: the evidence 10 years on; a partial replication , 2003, Journal of neurology, neurosurgery, and psychiatry.
[143] R. Nussbaum,et al. Alzheimer's disease and Parkinson's disease. , 2003, The New England journal of medicine.
[144] A. Hofman,et al. Silent brain infarcts and the risk of dementia and cognitive decline. , 2003, The New England journal of medicine.
[145] J. Dartigues,et al. Neurodegenerative diseases and exposure to pesticides in the elderly. , 2003, American journal of epidemiology.
[146] B. Winblad,et al. Alcohol consumption and incidence of dementia in a community sample aged 75 years and older. , 2002, Journal of clinical epidemiology.
[147] J. Lindsay,et al. Risk factors for Alzheimer's disease: a prospective analysis from the Canadian Study of Health and Aging. , 2002, American journal of epidemiology.
[148] J. Dichgans,et al. Treatment with simvastatin in normocholesterolemic patients with Alzheimer's disease: A 26‐week randomized, placebo‐controlled, double‐blind trial , 2002, Annals of neurology.
[149] Arto Mannermaa,et al. Apolipoprotein E 4 Allele, Elevated Midlife Total Cholesterol Level, and High Midlife Systolic Blood Pressure Are Independent Risk Factors for Late-Life Alzheimer Disease , 2002, Annals of Internal Medicine.
[150] E. Jéquier. Leptin Signaling, Adiposity, and Energy Balance , 2002, Annals of the New York Academy of Sciences.
[151] C. Cotman,et al. Exercise: a behavioral intervention to enhance brain health and plasticity , 2002, Trends in Neurosciences.
[152] L. Launer,et al. Type 2 diabetes, APOE gene, and the risk for dementia and related pathologies: The Honolulu-Asia Aging Study. , 2002, Diabetes.
[153] G. Lenzi,et al. A case-control study on Alzheimer’s disease and exposure to anesthesia , 2002, Neurological Sciences.
[154] J. Reif,et al. Occupational exposure to magnetic fields in case-referent studies of neurodegenerative diseases. , 2002, Scandinavian journal of work, environment & health.
[155] J. Belleville. The French paradox: possible involvement of ethanol in the protective effect against cardiovascular diseases. , 2002, Nutrition.
[156] Albert Hofman,et al. Alcohol consumption and risk of dementia: the Rotterdam Study , 2002, The Lancet.
[157] R. Green,et al. Risk of dementia among white and African American relatives of patients with Alzheimer disease. , 2002, JAMA.
[158] F. Sung,et al. Risk of Cognitive Impairment in Relation to Elevated Exposure to Electromagnetic Fields , 2002, Journal of occupational and environmental medicine.
[159] L. Beckett,et al. Annual Incidence of Alzheimer Disease in the United States Projected to the Years 2000 Through 2050 , 2001, Alzheimer disease and associated disorders.
[160] J Tuomilehto,et al. Midlife vascular risk factors and Alzheimer's disease in later life: longitudinal, population based study , 2001, BMJ.
[161] J. Manfreda,et al. Risk factors for Alzheimer's disease: a population-based, longitudinal study in Manitoba, Canada. , 2001, International journal of epidemiology.
[162] I. Fortier,et al. Environmental pesticide exposure as a risk factor for Alzheimer's disease: a case-control study. , 2001, Environmental research.
[163] D. Power,et al. Circulating Leptin Levels and Weight Loss in Alzheimer’s Disease Patients , 2001, Dementia and Geriatric Cognitive Disorders.
[164] J. Guralnik,et al. Documented head injury in early adulthood and risk of Alzheimer’s disease and other dementias , 2000, Neurology.
[165] C. DeCarli,et al. Head injury and the risk of AD in the MIRAGE study , 2000, Neurology.
[166] E. Rimm,et al. Moderate alcohol intake and lower risk of coronary heart disease: meta-analysis of effects on lipids and haemostatic factors , 1999, BMJ.
[167] Y. Stern,et al. Diabetes mellitus and the risk of dementia , 1999, Neurology.
[168] F. Gage,et al. Running increases cell proliferation and neurogenesis in the adult mouse dentate gyrus , 1999, Nature Neuroscience.
[169] T. Olsson,et al. Dual relation between leptin and cortisol in humans is disturbed in Alzheimer's disease. , 1998, Biological psychiatry.
[170] A. Smargiassi,et al. A case-control study of occupational and environmental risk factors for Parkinson's disease in the Emilia-Romagna region of Italy. , 1998, Neurotoxicology.
[171] A. Hofman,et al. Smoking and risk of dementia and Alzheimer's disease in a population-based cohort study: the Rotterdam Study , 1998, The Lancet.
[172] K Johansson,et al. Heritability for Alzheimer's disease: the study of dementia in Swedish twins. , 1997, The journals of gerontology. Series A, Biological sciences and medical sciences.
[173] E. Sobel,et al. Electromagnetic field exposure may cause increased production of amyloid beta and eventually lead to Alzheimer's disease , 1996, Neurology.
[174] S. Tyas. Are tobacco and alcohol use related to Alzheimer's disease? A critical assessment of the evidence and its implications , 1996, Addiction biology.
[175] J. Kaprio,et al. Alzheimer's disease in Finnish twins , 1996, The Lancet.
[176] E M Wijsman,et al. Interactions of apolipoprotein E genotype, total cholesterol level, age, and sex in prediction of Alzheimer's disease , 1995, Neurology.
[177] E B Larson,et al. Solvent exposure as a risk factor for Alzheimer's disease: a case-control study. , 1995, American journal of epidemiology.
[178] B. Tycko,et al. Synergistic Effects of Traumatic Head Injury and Apolipoprotein-epsilon4 in Patients With Alzheimer's Disease , 1995, Neurology.
[179] E. Baker. A review of recent research on health effects of human occupational exposure to organic solvents. A critical review. , 1994, Journal of occupational medicine. : official publication of the Industrial Medical Association.
[180] G. Belle,et al. Relationship between cigarette smoking and Alzheimer's disease in a population‐based case‐control study , 1992, Neurology.
[181] G. Nisticó,et al. Evidence that paraquat is able to cross the blood-brain barrier to a different extent in rats of various age. , 1991, Functional neurology.
[182] P C O'Brien,et al. Brain injury and neurologic sequelae , 1991, Neurology.
[183] D. Birkett,et al. The Relationship between Cancer and Alzheimer's Disease , 1991, Journal of the American Geriatrics Society.
[184] H. Riihimäki,et al. Occupational solvent exposure and neuropsychiatric disorders. , 1984, Scandinavian journal of work, environment & health.
[185] M. Folstein,et al. Clinical diagnosis of Alzheimer's disease , 1984, Neurology.
[186] R. Kimbrough,et al. The ultrastructure of livers of rats fed DDT and dieldrin. , 1971, Archives of environmental health.
[187] Stuart Maudsley,et al. Anti-inflammatory effects of physical activity in relationship to improved cognitive status in humans and mouse models of Alzheimer's disease. , 2012, Current Alzheimer research.
[188] Stuart Maudsley,et al. Metabolic dysfunction in Alzheimer's disease and related neurodegenerative disorders. , 2012, Current Alzheimer research.
[189] D. Loewenstein,et al. High Blood caffeine levels in MCI linked to lack of progression to dementia. , 2012, Journal of Alzheimer's disease : JAD.
[190] P. S. St George-Hyslop,et al. This month in archives of neurology. , 2012, Archives of neurology.
[191] M. Weiner,et al. Lipids and adipokines as risk factors for Alzheimer's disease. , 2012, Journal of Alzheimer's disease : JAD.
[192] M. Avidan,et al. Review of clinical evidence for persistent cognitive decline or incident dementia attributable to surgery or general anesthesia. , 2011, Journal of Alzheimer's disease : JAD.
[193] Neil M Davies,et al. Associations of anti-hypertensive treatments with Alzheimer's disease, vascular dementia, and other dementias. , 2011, Journal of Alzheimer's disease : JAD.
[194] T. Montine,et al. Intranasal Insulin Therapy for Alzheimer Disease and Amnestic Mild Cognitive Impairment A Pilot Clinical Trial , 2011 .
[195] L. White,et al. Coffee intake in midlife and risk of dementia and its neuropathologic correlates. , 2011, Journal of Alzheimer's disease : JAD.
[196] J. Delgado-García,et al. Physical exercise protects against Alzheimer's disease in 3xTg-AD mice. , 2011, Journal of Alzheimer's disease : JAD.
[197] K. Lunetta,et al. Identification of novel candidate genes for Alzheimer's disease by autozygosity mapping using genome wide SNP data. , 2011, Journal of Alzheimer's disease : JAD.
[198] C. Cao,et al. Caffeine synergizes with another coffee component to increase plasma GCSF: linkage to cognitive benefits in Alzheimer's mice. , 2011, Journal of Alzheimer's disease : JAD.
[199] M. Mena,et al. Anesthesia with isoflurane increases amyloid pathology in mice models of Alzheimer's disease. , 2010, Journal of Alzheimer's disease : JAD.
[200] S. Glantz,et al. Cigarette smoking is a risk factor for Alzheimer's Disease: an analysis controlling for tobacco industry affiliation. , 2010, Journal of Alzheimer's disease : JAD.
[201] C. Gong,et al. Anesthetics and tau protein: animal model studies. , 2010, Journal of Alzheimer's disease : JAD.
[202] V. Finder. Alzheimer's disease: a general introduction and pathomechanism. , 2010, Journal of Alzheimer's disease : JAD.
[203] F. Bilotta,et al. Postoperative cognitive dysfunction: toward the Alzheimer's disease pathomechanism hypothesis. , 2010, Journal of Alzheimer's disease : JAD.
[204] M. Bednar,et al. Iatrogenic risk factors for Alzheimer's disease: surgery and anesthesia. , 2010, Journal of Alzheimer's disease : JAD.
[205] Y. Ikeda,et al. Assessment of an ELISA kit for platelet-derived microparticles by joint research at many institutes in Japan. , 2009, Journal of atherosclerosis and thrombosis.
[206] H. Soininen,et al. Midlife coffee and tea drinking and the risk of late-life dementia: a population-based CAIDE study. , 2009, Journal of Alzheimer's disease : JAD.
[207] L. Chu,et al. Late-life body mass index and waist circumference in amnestic mild cognitive impairment and Alzheimer's disease. , 2009, Journal of Alzheimer's disease : JAD.
[208] D. Holtzman,et al. Caffeine suppresses amyloid-beta levels in plasma and brain of Alzheimer's disease transgenic mice. , 2009, Journal of Alzheimer's disease : JAD.
[209] Zachary Munn,et al. Cognitive Leisure Activities and their Role in Preventing Dementia: A Systematic Review , 2009, JBI library of systematic reviews.
[210] S. Cichon,et al. Bmc Medical Genomics a Genome-wide Association Study for Late-onset Alzheimer's Disease Using Dna Pooling , 2008 .
[211] A. J. Slater,et al. Candidate single-nucleotide polymorphisms from a genomewide association study of Alzheimer disease. , 2008, Archives of neurology.
[212] P. Barberger‐Gateau,et al. Nutritional factors and risk of incident dementia in the PAQUID longitudinal cohort. , 2004, The journal of nutrition, health & aging.
[213] J. Ashford,et al. Non-familial Alzheimer's disease is mainly due to genetic factors. , 2002, Journal of Alzheimer's disease : JAD.
[214] P. Lee,et al. Smoking and Alzheimer's disease: a review of the epidemiological evidence. , 1994, Neuroepidemiology.
[215] Blain Pg. Aspects of pesticide toxicology. , 1990 .